Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 28 entries
Sorted by: Best Match Show Resources per page
Headache: pregnancy and breastfeeding Recommendations of the Spanish Society of Neurology's Headache Study Group.

Neurologia (Barcelona, Spain)

González-García N, Díaz de Terán J, López-Veloso AC, Mas-Sala N, Mínguez-Olaondo A, Ruiz-Piñero M, Gago-Veiga AB, Santos-Lasaosa S, Viguera-Romero J, Pozo-Rosich P.
PMID: 31047730
Neurologia (Engl Ed). 2019 Apr 29; doi: 10.1016/j.nrl.2018.12.003. Epub 2019 Apr 29.

INTRODUCTION: Headache is one of the most common neurological complaints, and is most frequent during reproductive age. As a result, we are routinely faced with pregnant or breastfeeding women with this symptom in clinical practice. It is important to...

Cite
González-García N, Díaz de Terán J, López-Veloso AC, et al. Cefalea: embarazo y lactancia. Recomendaciones del Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología (GECSEN). Headache: pregnancy and breastfeeding Recommendations of the Spanish Society of Neurology's Headache Study Group. Neurologia (Engl Ed). 2019;doi: 10.1016/j.nrl.2018.12.003.
González-García, N., Díaz de Terán, J., López-Veloso, A. C., Mas-Sala, N., Mínguez-Olaondo, A., Ruiz-Piñero, M., Gago-Veiga, A. B., Santos-Lasaosa, S., Viguera-Romero, J., & Pozo-Rosich, P. (2019). Cefalea: embarazo y lactancia. Recomendaciones del Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología (GECSEN). Headache: pregnancy and breastfeeding Recommendations of the Spanish Society of Neurology's Headache Study Group. Neurologia (Barcelona, Spain), . https://doi.org/10.1016/j.nrl.2018.12.003
González-García, N, et al. "Cefalea: embarazo y lactancia. Recomendaciones del Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología (GECSEN)." Headache: pregnancy and breastfeeding Recommendations of the Spanish Society of Neurology's Headache Study Group. Neurologia (Barcelona, Spain) vol. (2019). doi: https://doi.org/10.1016/j.nrl.2018.12.003
González-García N, Díaz de Terán J, López-Veloso AC, Mas-Sala N, Mínguez-Olaondo A, Ruiz-Piñero M, Gago-Veiga AB, Santos-Lasaosa S, Viguera-Romero J, Pozo-Rosich P. Cefalea: embarazo y lactancia. Recomendaciones del Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología (GECSEN). Headache: pregnancy and breastfeeding Recommendations of the Spanish Society of Neurology's Headache Study Group. Neurologia (Engl Ed). 2019 Apr 29; doi: 10.1016/j.nrl.2018.12.003. Epub 2019 Apr 29. Spanish. PMID: 31047730.
Copy Download .nbib Format: NLM
Epidemiology, work and economic impact of migraine in a large hospital cohort: time to raise awareness and promote sustainability.

Journal of neurology

Caronna E, Gallardo VJ, Alpuente A, Torres-Ferrus M, Pozo-Rosich P.
PMID: 34282471
J Neurol. 2021 Jul 20; doi: 10.1007/s00415-021-10715-2. Epub 2021 Jul 20.

BACKGROUND: Migraine is not routinely assessed at work, making impossible to realize its impact and the potential benefit of migraine-related health strategies. We aimed to assess epidemiology, work and economic impact of migraine in a workplace cohort of a...

Cite
Caronna E, Gallardo VJ, Alpuente A, et al. Epidemiology, work and economic impact of migraine in a large hospital cohort: time to raise awareness and promote sustainability. J Neurol. 2021;doi: 10.1007/s00415-021-10715-2.
Caronna, E., Gallardo, V. J., Alpuente, A., Torres-Ferrus, M., & Pozo-Rosich, P. (2021). Epidemiology, work and economic impact of migraine in a large hospital cohort: time to raise awareness and promote sustainability. Journal of neurology, . https://doi.org/10.1007/s00415-021-10715-2
Caronna, Edoardo, et al. "Epidemiology, work and economic impact of migraine in a large hospital cohort: time to raise awareness and promote sustainability." Journal of neurology vol. (2021). doi: https://doi.org/10.1007/s00415-021-10715-2
Caronna E, Gallardo VJ, Alpuente A, Torres-Ferrus M, Pozo-Rosich P. Epidemiology, work and economic impact of migraine in a large hospital cohort: time to raise awareness and promote sustainability. J Neurol. 2021 Jul 20; doi: 10.1007/s00415-021-10715-2. Epub 2021 Jul 20. PMID: 34282471.
Copy Download .nbib Format: NLM
The MIGREX study: Prevalence and risk factors of sexual dysfunction among migraine patients.

Neurologia (Barcelona, Spain)

Torres-Ferrus M, López-Veloso AC, Gonzalez-Quintanilla V, González-García N, Díaz de Teran J, Gago-Veiga A, Camiña J, Ruiz M, Mas-Sala N, Bohórquez S, Gallardo VJ, Pozo-Rosich P.
PMID: 33766414
Neurologia (Engl Ed). 2021 Mar 22; doi: 10.1016/j.nrl.2021.02.006. Epub 2021 Mar 22.

BACKGROUND: Migraine attacks have a high impact on daily activities. There is limited research on the burden of migraine on sexual functioning.OBJECTIVE: To determine the prevalence of sexual dysfunction in patients with migraine and its relationship with migraine features...

Cite
Torres-Ferrus M, López-Veloso AC, Gonzalez-Quintanilla V, et al. The MIGREX study: Prevalence and risk factors of sexual dysfunction among migraine patients. Neurologia (Engl Ed). 2021;doi: 10.1016/j.nrl.2021.02.006.
Torres-Ferrus, M., López-Veloso, A. C., Gonzalez-Quintanilla, V., González-García, N., Díaz de Teran, J., Gago-Veiga, A., Camiña, J., Ruiz, M., Mas-Sala, N., Bohórquez, S., Gallardo, V. J., & Pozo-Rosich, P. (2021). The MIGREX study: Prevalence and risk factors of sexual dysfunction among migraine patients. Neurologia (Barcelona, Spain), . https://doi.org/10.1016/j.nrl.2021.02.006
Torres-Ferrus, M, et al. "The MIGREX study: Prevalence and risk factors of sexual dysfunction among migraine patients." Neurologia (Barcelona, Spain) vol. (2021). doi: https://doi.org/10.1016/j.nrl.2021.02.006
Torres-Ferrus M, López-Veloso AC, Gonzalez-Quintanilla V, González-García N, Díaz de Teran J, Gago-Veiga A, Camiña J, Ruiz M, Mas-Sala N, Bohórquez S, Gallardo VJ, Pozo-Rosich P. The MIGREX study: Prevalence and risk factors of sexual dysfunction among migraine patients. Neurologia (Engl Ed). 2021 Mar 22; doi: 10.1016/j.nrl.2021.02.006. Epub 2021 Mar 22. Spanish. PMID: 33766414.
Copy Download .nbib Format: NLM
Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications.

Neurologia (Barcelona, Spain)

Caronna E, José Gallardo V, Alpuente A, Torres-Ferrus M, Sánchez-Mateo NM, Viguera-Romero J, López-Veloso AC, López-Bravo A, Gago-Veiga AB, Irimia Sieira P, Porta-Etessam J, Santos-Lasaosa S, Pozo-Rosich P.
PMID: 33832802
Neurologia (Engl Ed). 2021 Mar 19; doi: 10.1016/j.nrl.2021.03.003. Epub 2021 Mar 19.

BACKGROUND AND OBJECTIVE: CGRP, a neuropeptide involved in migraine pathophysiology, is also known to play a role in the respiratory system and in immunological conditions such as sepsis. We analyzed the impact of the use of CGRP antagonists in...

Cite
Caronna E, José Gallardo V, Alpuente A, et al. Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications. Neurologia (Engl Ed). 2021;doi: 10.1016/j.nrl.2021.03.003.
Caronna, E., José Gallardo, V., Alpuente, A., Torres-Ferrus, M., Sánchez-Mateo, N. M., Viguera-Romero, J., López-Veloso, A. C., López-Bravo, A., Gago-Veiga, A. B., Irimia Sieira, P., Porta-Etessam, J., Santos-Lasaosa, S., Pozo-Rosich, P. (2021). Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications. Neurologia (Barcelona, Spain), . https://doi.org/10.1016/j.nrl.2021.03.003
Caronna, E, et al. "Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications." Neurologia (Barcelona, Spain) vol. (2021). doi: https://doi.org/10.1016/j.nrl.2021.03.003
Caronna E, José Gallardo V, Alpuente A, Torres-Ferrus M, Sánchez-Mateo NM, Viguera-Romero J, López-Veloso AC, López-Bravo A, Gago-Veiga AB, Irimia Sieira P, Porta-Etessam J, Santos-Lasaosa S, Pozo-Rosich P. Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications. Neurologia (Engl Ed). 2021 Mar 19; doi: 10.1016/j.nrl.2021.03.003. Epub 2021 Mar 19. Spanish. PMID: 33832802; PMCID: PMC7973059.
Copy Download .nbib Format: NLM
Diagnosis and management of migraine in ten steps.

Nature reviews. Neurology

Eigenbrodt AK, Ashina H, Khan S, Diener HC, Mitsikostas DD, Sinclair AJ, Pozo-Rosich P, Martelletti P, Ducros A, Lantéri-Minet M, Braschinsky M, Del Rio MS, Daniel O, Özge A, Mammadbayli A, Arons M, Skorobogatykh K, Romanenko V, Terwindt GM, Paemeleire K, Sacco S, Reuter U, Lampl C, Schytz HW, Katsarava Z, Steiner TJ, Ashina M.
PMID: 34145431
Nat Rev Neurol. 2021 Aug;17(8):501-514. doi: 10.1038/s41582-021-00509-5. Epub 2021 Jun 18.

Migraine is a disabling primary headache disorder that directly affects more than one billion people worldwide. Despite its widespread prevalence, migraine remains under-diagnosed and under-treated. To support clinical decision-making, we convened a European panel of experts to develop a...

Cite
Eigenbrodt AK, Ashina H, Khan S, et al. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021;17(8):501-514doi: 10.1038/s41582-021-00509-5.
Eigenbrodt, A. K., Ashina, H., Khan, S., Diener, H. C., Mitsikostas, D. D., Sinclair, A. J., Pozo-Rosich, P., Martelletti, P., Ducros, A., Lantéri-Minet, M., Braschinsky, M., Del Rio, M. S., Daniel, O., Özge, A., Mammadbayli, A., Arons, M., Skorobogatykh, K., Romanenko, V., Terwindt, G. M., Paemeleire, K., Sacco, S., Reuter, U., Lampl, C., Schytz, H. W., Katsarava, Z., Steiner, T. J., & Ashina, M. (2021). Diagnosis and management of migraine in ten steps. Nature reviews. Neurology, 17(8), 501-514. https://doi.org/10.1038/s41582-021-00509-5
Eigenbrodt, Anna K, et al. "Diagnosis and management of migraine in ten steps." Nature reviews. Neurology vol. 17,8 (2021): 501-514. doi: https://doi.org/10.1038/s41582-021-00509-5
Eigenbrodt AK, Ashina H, Khan S, Diener HC, Mitsikostas DD, Sinclair AJ, Pozo-Rosich P, Martelletti P, Ducros A, Lantéri-Minet M, Braschinsky M, Del Rio MS, Daniel O, Özge A, Mammadbayli A, Arons M, Skorobogatykh K, Romanenko V, Terwindt GM, Paemeleire K, Sacco S, Reuter U, Lampl C, Schytz HW, Katsarava Z, Steiner TJ, Ashina M. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021 Aug;17(8):501-514. doi: 10.1038/s41582-021-00509-5. Epub 2021 Jun 18. PMID: 34145431; PMCID: PMC8321897.
Copy Download .nbib Format: NLM
Headache during COVID-19: Lessons for all, implications for the International Classification of Headache Disorders.

Headache

Caronna E, Pozo-Rosich P.
PMID: 33522600
Headache. 2021 Feb;61(2):385-386. doi: 10.1111/head.14059. Epub 2021 Feb 01.

No abstract available.

Cite
Caronna E, Pozo-Rosich P. Headache during COVID-19: Lessons for all, implications for the International Classification of Headache Disorders. Headache. 2021;61(2):385-386doi: 10.1111/head.14059.
Caronna, E., & Pozo-Rosich, P. (2021). Headache during COVID-19: Lessons for all, implications for the International Classification of Headache Disorders. Headache, 61(2), 385-386. https://doi.org/10.1111/head.14059
Caronna, Edoardo, and Pozo-Rosich, Patricia. "Headache during COVID-19: Lessons for all, implications for the International Classification of Headache Disorders." Headache vol. 61,2 (2021): 385-386. doi: https://doi.org/10.1111/head.14059
Caronna E, Pozo-Rosich P. Headache during COVID-19: Lessons for all, implications for the International Classification of Headache Disorders. Headache. 2021 Feb;61(2):385-386. doi: 10.1111/head.14059. Epub 2021 Feb 01. PMID: 33522600; PMCID: PMC8013461.
Copy Download .nbib Format: NLM
Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study.

Pain and therapy

Pozo-Rosich P, Lucas C, Watson DPB, Gaul C, Ramsden E, Ritter S, Martelletti P, Snellman J.
PMID: 34643891
Pain Ther. 2021 Dec;10(2):1691-1708. doi: 10.1007/s40122-021-00331-3. Epub 2021 Oct 13.

INTRODUCTION: Migraine is consistently ranked as one of the most disabling neurological conditions in the world, often causing a substantial impairment of daily activities and quality of life. It also carries a high economic burden of direct and indirect...

Cite
Pozo-Rosich P, Lucas C, Watson DPB, et al. Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study. Pain Ther. 2021;10(2):1691-1708doi: 10.1007/s40122-021-00331-3.
Pozo-Rosich, P., Lucas, C., Watson, D. P. B., Gaul, C., Ramsden, E., Ritter, S., Martelletti, P., & Snellman, J. (2021). Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study. Pain and therapy, 10(2), 1691-1708. https://doi.org/10.1007/s40122-021-00331-3
Pozo-Rosich, Patricia, et al. "Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study." Pain and therapy vol. 10,2 (2021): 1691-1708. doi: https://doi.org/10.1007/s40122-021-00331-3
Pozo-Rosich P, Lucas C, Watson DPB, Gaul C, Ramsden E, Ritter S, Martelletti P, Snellman J. Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study. Pain Ther. 2021 Dec;10(2):1691-1708. doi: 10.1007/s40122-021-00331-3. Epub 2021 Oct 13. PMID: 34643891; PMCID: PMC8586314.
Copy Download .nbib Format: NLM
Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society.

Cephalalgia : an international journal of headache

Diener HC, Ashina M, Durand-Zaleski I, Kurth T, Lantéri-Minet M, Lipton RB, Ollendorf DA, Pozo-Rosich P, Tassorelli C, Terwindt G.
PMID: 33472427
Cephalalgia. 2021 Mar;41(3):279-293. doi: 10.1177/0333102421989247. Epub 2021 Jan 20.

The Clinical Trials Subcommittee of the International Headache Society presents the first Health Technology Assessment for the Acute Treatment of Migraine Attacks and Prevention of Migraine. Health technology assessments are systematic evaluations of the properties, effects, and consequences of...

Cite
Diener HC, Ashina M, Durand-Zaleski I, et al. Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society. Cephalalgia. 2021;41(3):279-293doi: 10.1177/0333102421989247.
Diener, H. C., Ashina, M., Durand-Zaleski, I., Kurth, T., Lantéri-Minet, M., Lipton, R. B., Ollendorf, D. A., Pozo-Rosich, P., Tassorelli, C., & Terwindt, G. (2021). Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society. Cephalalgia : an international journal of headache, 41(3), 279-293. https://doi.org/10.1177/0333102421989247
Diener, Hans Christoph, et al. "Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society." Cephalalgia : an international journal of headache vol. 41,3 (2021): 279-293. doi: https://doi.org/10.1177/0333102421989247
Diener HC, Ashina M, Durand-Zaleski I, Kurth T, Lantéri-Minet M, Lipton RB, Ollendorf DA, Pozo-Rosich P, Tassorelli C, Terwindt G. Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society. Cephalalgia. 2021 Mar;41(3):279-293. doi: 10.1177/0333102421989247. Epub 2021 Jan 20. PMID: 33472427; PMCID: PMC7961634.
Copy Download .nbib Format: NLM
How does the brain change in chronic migraine? Developing disease biomarkers.

Cephalalgia : an international journal of headache

Pozo-Rosich P, Coppola G, Pascual J, Schwedt TJ.
PMID: 33291995
Cephalalgia. 2021 Apr;41(5):613-630. doi: 10.1177/0333102420974359. Epub 2020 Dec 08.

BACKGROUND: Validated chronic migraine biomarkers could improve diagnostic, prognostic, and predictive abilities for clinicians and researchers, as well as increase knowledge on migraine pathophysiology.OBJECTIVE: The objective of this narrative review is to summarise and interpret the published literature regarding...

Cite
Pozo-Rosich P, Coppola G, Pascual J, et al. How does the brain change in chronic migraine? Developing disease biomarkers. Cephalalgia. 2020;41(5):613-630doi: 10.1177/0333102420974359.
Pozo-Rosich, P., Coppola, G., Pascual, J., & Schwedt, T. J. (2021). How does the brain change in chronic migraine? Developing disease biomarkers. Cephalalgia : an international journal of headache, 41(5), 613-630. https://doi.org/10.1177/0333102420974359
Pozo-Rosich, Patricia, et al. "How does the brain change in chronic migraine? Developing disease biomarkers." Cephalalgia : an international journal of headache vol. 41,5 (2021): 613-630. doi: https://doi.org/10.1177/0333102420974359
Pozo-Rosich P, Coppola G, Pascual J, Schwedt TJ. How does the brain change in chronic migraine? Developing disease biomarkers. Cephalalgia. 2021 Apr;41(5):613-630. doi: 10.1177/0333102420974359. Epub 2020 Dec 08. PMID: 33291995.
Copy Download .nbib Format: NLM
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine.

Cephalalgia : an international journal of headache

Tassorelli C, Diener HC, Silberstein SD, Dodick DW, Goadsby PJ, Jensen RH, Magis D, Pozo-Rosich P, Yuan H, Martinelli D, Hoek TVD, Deen M, Ashina M, Terwindt GM.
PMID: 33990161
Cephalalgia. 2021 Oct;41(11):1135-1151. doi: 10.1177/03331024211010413. Epub 2021 May 14.

BACKGROUND: Although the European Medicines Agency and the US Food and Drug Administration have cleared several devices that use neuromodulation to provide clinical benefits in the acute or preventive treatment of migraine, the Clinical Trials Committee of the International...

Cite
Tassorelli C, Diener HC, Silberstein SD, et al. Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine. Cephalalgia. 2021;41(11):1135-1151doi: 10.1177/03331024211010413.
Tassorelli, C., Diener, H. C., Silberstein, S. D., Dodick, D. W., Goadsby, P. J., Jensen, R. H., Magis, D., Pozo-Rosich, P., Yuan, H., Martinelli, D., Hoek, T. V. D., Deen, M., Ashina, M., & Terwindt, G. M. (2021). Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine. Cephalalgia : an international journal of headache, 41(11), 1135-1151. https://doi.org/10.1177/03331024211010413
Tassorelli, Cristina, et al. "Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine." Cephalalgia : an international journal of headache vol. 41,11 (2021): 1135-1151. doi: https://doi.org/10.1177/03331024211010413
Tassorelli C, Diener HC, Silberstein SD, Dodick DW, Goadsby PJ, Jensen RH, Magis D, Pozo-Rosich P, Yuan H, Martinelli D, Hoek TVD, Deen M, Ashina M, Terwindt GM. Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine. Cephalalgia. 2021 Oct;41(11):1135-1151. doi: 10.1177/03331024211010413. Epub 2021 May 14. PMID: 33990161.
Copy Download .nbib Format: NLM
CADASIL management or what to do when there is little one can do.

Expert review of neurotherapeutics

del Río-Espínola A, Mendióroz M, Domingues-Montanari S, Pozo-Rosich P, Solé E, Fernández-Morales J, Fernández-Cadenas I, Montaner J.
PMID: 19210195
Expert Rev Neurother. 2009 Feb;9(2):197-210. doi: 10.1586/14737175.9.2.197.

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a rare disease that leads to migraine, mood disorders, recurrent lacunar strokes and early vascular dementia. This autosomal-dominant condition is caused by mutations in the NOTCH3 gene and...

Cite
del Río-Espínola A, Mendióroz M, Domingues-Montanari S, et al. CADASIL management or what to do when there is little one can do. Expert Rev Neurother. 2009;9(2):197-210doi: 10.1586/14737175.9.2.197.
del Río-Espínola, A., Mendióroz, M., Domingues-Montanari, S., Pozo-Rosich, P., Solé, E., Fernández-Morales, J., Fernández-Cadenas, I., & Montaner, J. (2009). CADASIL management or what to do when there is little one can do. Expert review of neurotherapeutics, 9(2), 197-210. https://doi.org/10.1586/14737175.9.2.197
del Río-Espínola, Alberto, et al. "CADASIL management or what to do when there is little one can do." Expert review of neurotherapeutics vol. 9,2 (2009): 197-210. doi: https://doi.org/10.1586/14737175.9.2.197
del Río-Espínola A, Mendióroz M, Domingues-Montanari S, Pozo-Rosich P, Solé E, Fernández-Morales J, Fernández-Cadenas I, Montaner J. CADASIL management or what to do when there is little one can do. Expert Rev Neurother. 2009 Feb;9(2):197-210. doi: 10.1586/14737175.9.2.197. PMID: 19210195.
Copy Download .nbib Format: NLM
Poster 411 The Impact of OnabotulinumtoxinA on Severe Headache Days: PREEMPT 24-Week Pooled Analysis.

PM & R : the journal of injury, function, and rehabilitation

Aurora S, Halker R, Pozo-Rosich P, DeGryse R, Manack Adams A, Matharu M.
PMID: 27673163
PM R. 2016 Sep;8(9):S296. doi: 10.1016/j.pmrj.2016.07.338. Epub 2016 Sep 24.

No abstract available.

Cite
Aurora S, Halker R, Pozo-Rosich P, et al. Poster 411 The Impact of OnabotulinumtoxinA on Severe Headache Days: PREEMPT 24-Week Pooled Analysis. PM R. 2016;8(9):S296doi: 10.1016/j.pmrj.2016.07.338.
Aurora, S., Halker, R., Pozo-Rosich, P., DeGryse, R., Manack Adams, A., & Matharu, M. (2016). Poster 411 The Impact of OnabotulinumtoxinA on Severe Headache Days: PREEMPT 24-Week Pooled Analysis. PM & R : the journal of injury, function, and rehabilitation, 8(9), S296. https://doi.org/10.1016/j.pmrj.2016.07.338
Aurora, Sheena, et al. "Poster 411 The Impact of OnabotulinumtoxinA on Severe Headache Days: PREEMPT 24-Week Pooled Analysis." PM & R : the journal of injury, function, and rehabilitation vol. 8,9 (2016): S296. doi: https://doi.org/10.1016/j.pmrj.2016.07.338
Aurora S, Halker R, Pozo-Rosich P, DeGryse R, Manack Adams A, Matharu M. Poster 411 The Impact of OnabotulinumtoxinA on Severe Headache Days: PREEMPT 24-Week Pooled Analysis. PM R. 2016 Sep;8(9):S296. doi: 10.1016/j.pmrj.2016.07.338. Epub 2016 Sep 24. PMID: 27673163.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 28 entries